Finance ❯ Stock Market ❯ Company Valuation ❯ Investor Sentiment

Stock Performance

Organon CEO Resigns After Probe Finds Improper Nexplanon Wholesaler Sales

Board investigators found excess Nexplanon shipments to U.S. wholesalers from 2022 to 2025 that made sales statements inaccurate.

Elon Musk steps down as Trump’s efficiency chief after 130 days